Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRIVE pilot study of rotigotine for sleep disorders in patients with disorders of consciousness
2019-001898-87Phase 2Completed
- Sponsor
- Carlo Besta Neurological Institute
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of rotigotine in sleep-related movement disorders (SRMD), sleep bruxism, obstructive sleep apnea hypopnea syndrome (OSAHS) and 1 more, sponsored by Carlo Besta Neurological Institute. Started May 2021; status: completed.
02
Drugs
rotigotine
03
Conditions
sleep-related movement disorders (SRMD)sleep bruxismobstructive sleep apnea hypopnea syndrome (OSAHS)disorder of consciousness (DOC)
Beyond the preview
Go deeper on 2019-001898-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001898-87.